Darin Lippoldt Neurocrine Biosciences Inc (NBIX) insider trading activity

NBIX Quotes by TradingView

Darin Lippoldt is Chief Legal Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 43,405 shares of NBIX, which is worth approximately $5.24 Million. The most recent transaction as insider was on Feb 13, 2025, when has been sold 2,184 shares (Common Stock) at a price of $116.76 per share, resulting in proceeds of $255,003. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.4K
9.22% 3M change
9.22% 12M change
Total Value Held $5.24 Million

Darin Lippoldt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2025
SELL
Open market or private sale
$255,003 $116.76 p/Share
2,184 Reduced 4.79%
43,405 Common Stock
Feb 13 2025
BUY
Exercise of conversion of derivative security
-
4,100 Added 8.44%
44,491 Common Stock
Feb 12 2025
SELL
Bona fide gift
-
190 Reduced 0.46%
41,489 Common Stock
Feb 10 2025
SELL
Open market or private sale
$107,725 $118.25 p/Share
911 Reduced 2.14%
41,679 Common Stock
Feb 08 2025
BUY
Exercise of conversion of derivative security
-
1,727 Added 3.9%
42,590 Common Stock
Jan 31 2025
SELL
Open market or private sale
$191,137 $152.91 p/Share
1,250 Reduced 2.97%
40,863 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
2,373 Added 5.33%
42,113 Common Stock
Aug 01 2024
SELL
Open market or private sale
$461,413 $154.01 p/Share
2,996 Reduced 7.01%
39,740 Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
$236,743 $79.02 p/Share
2,996 Added 6.55%
42,736 Common Stock
Jul 16 2024
SELL
Open market or private sale
$1,050,600 $150.0 p/Share
7,004 Reduced 14.98%
39,740 Common Stock
Jul 16 2024
BUY
Exercise of conversion of derivative security
$553,456 $79.02 p/Share
7,004 Added 13.03%
46,744 Common Stock
Feb 13 2024
SELL
Open market or private sale
$146,023 $132.99 p/Share
1,098 Reduced 2.69%
39,740 Common Stock
Feb 08 2024
SELL
Open market or private sale
$122,292 $134.24 p/Share
911 Reduced 2.3%
38,755 Common Stock
Feb 06 2024
SELL
Open market or private sale
$147,998 $142.17 p/Share
1,041 Reduced 2.67%
37,939 Common Stock
Jan 31 2024
SELL
Open market or private sale
$175,812 $140.65 p/Share
1,250 Reduced 3.27%
37,005 Common Stock
Jan 22 2024
SELL
Open market or private sale
$1,398,600 $139.86 p/Share
10,000 Reduced 21.8%
35,882 Common Stock
Jan 22 2024
BUY
Exercise of conversion of derivative security
$790,200 $79.02 p/Share
10,000 Added 17.89%
45,882 Common Stock
Dec 06 2023
SELL
Open market or private sale
$2,496,683 $119.86 p/Share
20,830 Reduced 36.73%
35,882 Common Stock
Dec 06 2023
BUY
Exercise of conversion of derivative security
$900,689 $43.24 p/Share
20,830 Added 26.86%
56,712 Common Stock
Nov 27 2023
SELL
Open market or private sale
$1,225,876 $112.27 p/Share
10,919 Reduced 23.33%
35,882 Common Stock
Aug 30 2023
SELL
Bona fide gift
-
190 Reduced 0.4%
46,801 Common Stock
Aug 21 2023
SELL
Open market or private sale
$228,955 $107.39 p/Share
2,132 Reduced 4.34%
46,991 Common Stock
Feb 08 2023
SELL
Open market or private sale
$94,816 $104.08 p/Share
911 Reduced 1.99%
44,973 Common Stock
Feb 07 2023
SELL
Open market or private sale
$1,465,672 $102.33 p/Share
14,323 Reduced 24.49%
44,157 Common Stock
Feb 06 2023
SELL
Open market or private sale
$110,137 $105.8 p/Share
1,041 Reduced 3.22%
31,290 Common Stock
DL

Darin Lippoldt

Chief Legal Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIX